161
Participants
Start Date
January 31, 2014
Primary Completion Date
February 28, 2015
Study Completion Date
April 30, 2015
natalizumab
Administered as described in the treatment arm
Placebo
Matched placebo
Research Site, Barcelona
Research Site, Barcelona
Research Site, Barcelona
Research Site, Badalona
Research Site, New York
Research Site, Berlin
Research Site, Santiago de Compostela
Research Site, Girona
Research Site, Philadelphia
Research Site, Durham
Research Site, Madrid
Research Site, Pamplona
Research Site, Düsseldorf
Research Site, Seville
Research Site, Seville
Research Site, Dayton
Research Site, Valladolid
Research Site, Trier
Research Site, Golden Valley
Research Site, Idar-Oberstein
Research Site, Frankfurt
Research Site, St Louis
Research Site, Kansas City
Research Site, Ludwigshafen
Research Site, Heidelberg
Research Site, Tübingen
Research Site, Erlangen
Research Site, Tualatin
Research Site, Bad Neustadt an der Saale
Research Site, San Diego
Research Site, Gainesville
Research Site, Lake Success
Research Site, Akron
Research Site, Toledo
Research Site, Portland
Research Site, Nashville
Research Site, Dallas
Research Site, Charlottesville
Research Site, Milwaukee
Research Site, Bonn
Research Site, Hanover
Research Site, Ludwigshafen
Research Site, Mannheim
Research Site, Ulm
Research Site, Barakaldo
Research Site, Valencia
Research Site, Boston
Research Site, Altenburg
Research Site, Leipzig
Research Site, Albacete
Lead Sponsor
Biogen
INDUSTRY